Skip to main content
Erschienen in: Diabetes Therapy 3/2020

Open Access 12.02.2020 | Correction

Correction to: Study Protocol for the Effects of Formula Diet with Dapagliflozin on Metabolic Improvement and Body Composition in Type 2 Diabetes Mellitus

verfasst von: Yasuhiro Watanabe, Nobuichi Kuribayashi, Daigaku Uchida, Daisuke Suzuki, Mitsutoshi Kato, Daiji Nagayama, Hiroshi Ohashi, Masahiro Ohira, Atsuhito Saiki, Ichiro Tatsuno

Erschienen in: Diabetes Therapy | Ausgabe 3/2020

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise
The original article can be found online at https://​doi.​org/​10.​1007/​s13300-018-0555-5.

Correction to: Diabetes Ther (2019) 10:311–321 https://​doi.​org/​10.​1007/​s13300-018-0555-5

In the original article, the 6th sentence of the section “FD and calorie intake” is incorrect. The correct sentence is “The protein component of FD consists of whey protein, casein, and soy protein”.
There is a correction in the “Inclusion criteria” section, the correct sentence is Estimated glomerular filtration rate (eGFR) ≥ 45 ml/min/1.73 m2.

Open Access

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://​creativecommons.​org/​licenses/​by-nc/​4.​0/​), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
download
DOWNLOAD
print
DRUCKEN
Metadaten
Titel
Correction to: Study Protocol for the Effects of Formula Diet with Dapagliflozin on Metabolic Improvement and Body Composition in Type 2 Diabetes Mellitus
verfasst von
Yasuhiro Watanabe
Nobuichi Kuribayashi
Daigaku Uchida
Daisuke Suzuki
Mitsutoshi Kato
Daiji Nagayama
Hiroshi Ohashi
Masahiro Ohira
Atsuhito Saiki
Ichiro Tatsuno
Publikationsdatum
12.02.2020
Verlag
Springer Healthcare
Erschienen in
Diabetes Therapy / Ausgabe 3/2020
Print ISSN: 1869-6953
Elektronische ISSN: 1869-6961
DOI
https://doi.org/10.1007/s13300-020-00757-6

Weitere Artikel der Ausgabe 3/2020

Diabetes Therapy 3/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.